Ligand Pharmaceuticals (LGND) Return on Assets (2011 - 2026)

Ligand Pharmaceuticals has disclosed Return on Assets across 15 years of filings, most recently posting 0.0% for Q1 2026.

• Return on Assets for Q1 2026 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Assets came in at 0.0% for Q1 2026 at Ligand Pharmaceuticals, up from 0.0% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.0% in Q1 2026 to a low of 0.0% in Q1 2025.
• The 5-year median for Return on Assets is 0.0% (2022), against an average of 0.0%.
• Peak annual rise in Return on Assets reached 0 bps in 2022, while the deepest fall reached 0 bps in 2022.
• Ligand Pharmaceuticals' Return on Assets stood at 0.0% in 2022, then surged by 93 bps to 0.0% in 2023, then tumbled by 1432 bps to 0.0% in 2024, then surged by 350 bps to 0.0% in 2025, then advanced by 21 bps to 0.0% in 2026.
• The last three Return on Assets figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.